Rentokil stock gains 1.11 percent as analysts reset targets

Published on 10/03/2026 at 21:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Rentokil stock stood at GBp 299.40 on October 2, 2026, 2.01 percent above its 52-week low. RBC set a GBp 480.00 target, while Morgan Stanley cut its target to GBp 420.00.

Trading-Floor der Börse mit großen Bildschirmen und Aktiencharts im Hintergrund — Börsen-Editorial zeigt Trading-Floor mit Charts, relevant für Rentokil Initial plc, ISIN GB00B082RF11, gelistetes Unternehmen, Illustration mit AI erstellt.

Rentokil stock (ISIN GB00B082RF11) last traded at GBp 299.40 on the London Stock Exchange on October 2, 2026, up 1.11 percent on the session. The price was 2.01 percent above the 52-week low of GBp 293.50, keeping the yearly range central to the debate over the pest-control group's turnaround.

Analysts split on recovery

Business Insider reported on October 3, 2026, that RBC Capital analyst Andrew Brooke maintained a Buy rating on October 1 and set a GBp 480.00 price target. That target lies 60.3 percent above the GBp 299.40 reference price, a large gap that makes execution more important than a simple one-day rebound.

Investing.com reported on September 29, 2026, that Morgan Stanley downgraded Rentokil from Overweight to Equal-weight and reduced its target from GBp 500.00 to GBp 420.00. The brokerage cited tougher US pest-control competition and said Rentokil's adjusted EBITA margin was 15.5 percent in fiscal year 2025, compared with 22.4 percent for Rollins.

Portfolio simplification adds cash

Rentokil announced on September 22, 2026, an agreement to sell SOLitude Lake Management and its Vertex Aquatic Solutions division to Bain Capital for USD 230 million. The company said the disposal supports simplification and balance-sheet priorities, while the business generated FY 2025 revenue of USD 112 million and adjusted operating profit of USD 16 million, according to Rentokil Initial.

The next measurable test is the Q3 trading update scheduled for October 22, 2026, on the company's investor calendar. Rentokil Initial lists the event as a sales and revenue release, giving investors a concrete checkpoint for US organic growth and margin recovery.

Stock stays near yearly low

Rentokil stock was last at GBp 299.40 on October 2, 2026, with a market capitalization of GBP 7.5 billion and volume of 4,682,480 shares. The combination of a 1.11 percent daily gain, a GBp 293.50 yearly low and sharply different analyst targets leaves the October trading update as the next major valuation test.